Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,792,960
+$85,324 QoQ
Shares Held
13,953
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,665
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILTON INVESTMENT CO INC. holds $21,642,442 across 10 Drug Manufacturers - General names. MRK ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,720 | $6,860,740 | |
| 2 | JNJ |
Johnson & Johnson
|
20,745 | $5,268,607 | |
| 3 | ABBV |
AbbVie Inc.
|
16,964 | $4,268,820 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
13,953 | $1,792,960 | |
| 5 | AMGN |
Amgen Inc
|
3,302 | $1,195,720 | |
| 6 | AZN |
Astrazeneca PLC
|
5,268 | $998,918 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,562 | $435,722 | |
| 8 | NVS |
Novartis AG
|
2,250 | $352,620 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,792,960 | 13,953 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,707,636 | 14,196 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,586,899 | 15,076 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,101,916 | 13,129 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $604,861 | 7,641 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $285,795 | 3,184 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,561,311 | 25,747 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,182,178 | 28,022 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,585,743 | 28,964 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,393,686 | 56,034 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,677,568 | 107,114 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,789,993 | 124,235 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,806,182 | 119,648 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,269,892 | 105,930 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,676,488 | 105,241 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $10,633,753 | 123,476 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $11,364,431 | 124,651 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $6,939,460 | 84,576 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,018,695 | 52,436 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,238,653 | 29,805 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,134,397 | 27,445 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $10,198,472 | 132,293 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $14,159,246 | 173,096 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $8,135,988 | 98,083 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $5,908,787 | 76,410 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,841,942 | 23,940 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||